London-based Sinclair Pharma enjoys a rise in revenue thanks to demand for of injectable aesthetics
CEO Chris Spooner says that despite competition from bigger firms, ‘what we offer is radically better’
Published: 10:25am, 25 Oct, 2016
Updated: 10:25am, 25 Oct, 2016
Copyright © 2019 South China Morning Post Publishers Ltd. All rights reserved.